To determine donor morbidity associated with right lobectomy for living donor liver transplantation (LDLT) to adult recipients.
A meta-analysis was not carried out due to heterogeneity, but the data were combined by summing the events and denominators for each study to provide crude summary rates.
How were differences between studies investigated?
Differences were noted with respect to study duration, assessment measures and clinical outcomes, but these were not investigated further.
Results of the review
Twelve studies were included. One study was a chart review, one a multicentre survey and two were donor surveys, whilst the remaining eight studies did not report how the data were collected. Eleven studies were based on single centres. The studies took place in the USA, Japan, Hong Kong and Europe. There were 409 reported cases in total, with 38% (n=148) from the Asian studies. The sample size ranged from one case to 111 cases in the multicentre survey.
Morbidity ranged from 0% (0 out of 1) to 67% (9 out of 15), although no study gave a definition of morbidity so the reported events may exclude minor events in some studies. Of the 54 reported events in 174 right lobe donors, the most common were bile leak, prolonged ileus, and minor wound complications. The two largest studies did not report morbidity separately for the right and left lobes, so they did not contribute data to this outcome. Two of the 3 studies that reported readmissions had no donors readmitted (out of a total of 51 donors), while 4 of the 14 donors in the third study were readmitted. Of the 7 studies that reported mortality, 5 studies had 0% mortality. Two donor deaths were reported, one of which was in a study that did not differentiate between right and left lobe donors or between donors to adult and child recipients.
The overall mean hospital stay was 9.9 days in 8 studies (n=175), with the study means ranging from 5.4 to 16.5 days. Two studies included the self-reported time to complete recovery. One reported that 24 donors recovered within 3.4 months, while the other reported a mean recovery time of 13 weeks (range: 4 to 52) for 14 donors. In the 3 studies reporting return to pre-donation occupation, one of the 60 donors could not return due to chronic fatigue syndrome. One study reported a majority requiring a period (mean: 2.8 months) of light duties first.
Two studies reported health-related quality of life indices. In spite of some mild continuing symptoms, all 24 donors in one study reported that they would donate again. The other reported no significant changes in physical or social activity or emotional stability, and all would donate again.
